Axial Biotech hires VP for reimbursement and regulatory affairs
This article was originally published in Clinica
Rina Wolf has joined Axial Biotech (Salt Lake City, Utah), a firm specialising in diagnostic tests and implants for spinal conditions, as its vice-president of reimbursement and regulatory affairs. Her primary remit will be to achieve appropriate levels of insurance for the firm’s products. Ms Wolf joins from RedPath Integrated Pathology (cancer diagnostics) where she served in the same capacity. She has broad experience in the field and CEO of Axial John Climaco described Ms Wolf’s knowledge of molecular diagnostics regulations as “second to none”.